Less is More in Emerging Obesity Devices
This article was originally published in Start Up
By now it's obvious that obesity is more than a cosmetic problem. It's associated with heart disease, high blood pressure, certain cancers, and many other serious diseases. But it's coming to light that even being overweight increases one's cardiac risk. Now, companies with non-invasive and non-surgical devices for moderate obesity are a promising investments, according to "US Markets for Obesity Drugs and Bariatric Surgical Devices, " a report just published by Medtech Insight.
You may also be interested in...
At this year's American Society for Bariatric Surgery (ASBS) meeting, held in San Diego in June, innovation was on display as researchers and device manufacturers showcased several new approaches and technologies for bariatric surgery.
Obesity has become an epidemic, with 30% of the U.S. population obese and an additional 35% overweight, including children and adolescents. Bariatric surgical procedures have skyrocketed in recent years, with hospital costs exceeding $1.2 billion, and good success rates. However, for certain groups, such as patients over 65, the risks of bariatric surgery may outweigh the benefits. Much needs to be done to address this troubling and growing public health problem.
The push to improve healthcare quality in the U.S. has been a consistent goal, imbedded in the industry for years. However, over the last decade this movement rose to a higher level of necessity, and a number of programs have been generated from within the industry as well as government agencies -- but, has significant progress been made?